InspireMD, Inc.
(NASDAQ : NSPR)

( )
NSPR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -0.94%263.690.7%$634.99m
TMOThermo Fisher Scientific, Inc. -0.06%517.541.0%$625.66m
MDTMedtronic Plc -0.10%82.450.6%$549.23m
ABTAbbott Laboratories 0.18%98.830.8%$540.51m
ISRGIntuitive Surgical, Inc. -0.76%190.940.8%$341.30m
SYKStryker Corp. 0.32%205.791.3%$302.78m
BSXBoston Scientific Corp. -0.03%39.121.0%$252.17m
BDXBecton, Dickinson & Co. -0.04%230.281.0%$251.95m
EWEdwards Lifesciences Corp. -0.88%83.460.4%$240.80m
DXCMDexCom, Inc. 0.00%83.331.9%$195.93m
AAgilent Technologies, Inc. 0.01%123.731.7%$188.96m
ALGNAlign Technology, Inc. 0.00%212.106.4%$186.09m
IDXXIDEXX Laboratories, Inc. 0.00%334.033.9%$181.19m
BAXBaxter International, Inc. 0.00%55.561.8%$170.76m
SWAVShockwave Medical, Inc. 0.00%273.520.0%$137.46m

Company Profile

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.